EGRX   $2.13  -40.17% Market Closed

Eagle Pharmaceuticals Inc
Total Cash 15.35M
totalCashPerShare 1.182
EBITDA 62.33M
Total Debt 72.45M
quickRatio 1.506
currentRatio 2.161
Total Revenue 257.55M
debtToEquity 28.747
Revenue/Share 19.684
ROA 0.06628
ROE 0.04877
grossProfits
freeCashflow 38.31M
operatingCashflow -9.32M
earningsGrowth
revenueGrowth -0.128
grossMargins 0.69841003
ebitdaMargins 0.24200001
operatingMargins 0.15939
profitMargins 0.04639
enterpriseValue 67.49M
forwardPE
floatShares 8.26M
sharesOutstanding 12.96M
sharesShort 350.53K
sharesShortPriorMonth 484.16K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.78%
Short Ratio help_outline 3.91%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 19.248
Price To Book help_outline 0.04
earningsQuarterlyGrowth
netIncomeToCommon 11.95M
trailingEps 0.85%
forwardEps 3.48%
enterpriseToEbitda 1.08
lastDividendValue
lastDividendDate
currentQuarterEstimate 3Q 2023
institutionsCount 93
lastUpdated Nov. 6, 2024, 5:23 p.m.